Patient Derived Xenograft (PDX) Models Market Expects Significant Growth, Reaching $710 Million by 2028 - Global Long-term Forecasts to 2033 [Yahoo! Finance]
Inotiv, Inc. (NOTV)
Company Research
Source: Yahoo! Finance
The patient derived xenograft (PDX) models market is anticipated to expand significantly, from $0.35 billion in 2023 to $0.4 billion in 2024, according to recent data. This market demonstrates a robust compound annual growth rate (CAGR) of 16%, and is projected to continue this growth trajectory, potentially reaching a valuation of $0.74 billion by 2028 at a CAGR of 16.1%. This upsurge is largely driven by an increased focus on personalized medicine, a growing need for humanized PDX models, and a rise in global cancer incidence. Moreover, the market is buoyed by advancing technology in precision oncology, alongside amplified research and development funding for cancer treatment innovations. Growth Factors and Industry Trends The surge of personalized healthcare, which holds the promise of tailoring treatments to individual patient profiles, is a significant factor fueling market expansion. PDX models stand at the forefront of personalized medicine, propelling the demand for hum
Show less
Read more
Impact Snapshot
Event Time:
NOTV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NOTV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NOTV alerts
High impacting Inotiv, Inc. news events
Weekly update
A roundup of the hottest topics
NOTV
News
- Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ [Yahoo! Finance]Yahoo! Finance
- Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™GlobeNewswire
- Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024 [Yahoo! Finance]Yahoo! Finance
- Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024GlobeNewswire
- Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor ConferencesGlobeNewswire
NOTV
Earnings
- 8/8/24 - Miss
NOTV
Sec Filings
- 10/16/24 - Form EFFECT
- 10/3/24 - Form S-3
- 9/19/24 - Form 8-K
- NOTV's page on the SEC website